Read more about our nutrition story, our vision and the values that drive us.
Ask any of the 20,000 employees at Dr. Reddy’s why they come to work every day, and you are bound to hear, because ‘Good Health Can’t Wait.’ These simple words describe the deep-rooted belief that drives us. Sometimes, the simplest words describe the most profound truths.
Our belief is guided by our principles - Empathy and Dynamism - which provide both guidance for our current behavior and inspiration for our future actions.
As a company we made our first foray into the nutrition space in India with a diabetic nutrition supplement, CELEVIDA in Nov 2019 following which we entered hospital nutrition segment in July 2020 with CELEVIDA Maxx in our endeavor to continue making a positive impact on patient lives.
Scientist and entrepreneur Dr. K Anji Reddy established Dr. Reddy’s Laboratories with the vision to make medicines accessible to everyone. Beginning with the manufacture of active ingredients (APIs) for Ibuprofen and then Methyldopa, the anti-hypertensive drug previously unavailable in India, we later branched into formulations. In 1988, we became the largest exporter of Ibuprofen API in India with sales to the US, Spain, Italy and Japan. We also began to export active ingredients for Norfloxacin and Ciprofloxacin to Europe and the Far East in 1990. This was a first for an Indian pharmaceutical company.